Mangoceuticals, Inc. Common Stock (MGRX) is a publicly traded Healthcare sector company. As of May 21, 2026, MGRX trades at $0.40 with a market cap of $6.87M and a P/E ratio of -0.19. MGRX moved +1.62% today. Year to date, MGRX is -48.49%; over the trailing twelve months it is -72.97%. Its 52-week range spans $0.16 to $7.66. Rallies surfaces MGRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for MGRX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $0.40 |
| Market Cap | $6.87M |
| P/E Ratio | -0.19 |
| EPS | $-2.17 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.66 |
| 52-Week Low | $0.16 |
| Volume | 69 |
| Avg Volume | 0 |
| Revenue (TTM) | $456.02K |
| Net Income | $-20.64M |
| Gross Margin | 54.91% |
MGRX analyst coverage data. Average price target: $0.00.